Home › Funds › Fidelity › Fidelity Series Growth Company Fund
Fund family: Fidelity · Filed by FIDELITY MT VERNON STREET TRUST (CIK 707823) · SEC series S000042626
Ticker: FCGSX (C000131783)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 3,637 with, 211 against, 8 abstentions (not counted as with management); 14 items carried no recommendation. Shareholder proposals: 37 FOR, 184 AGAINST, 2 abstained, by the filing’s own vote-source field.
The same two figures as Fidelity’s manager page (1,165,189 ballot items across 406 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Fidelity | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.9% | 3,472 | 94.1% | 974,562 |
| Backed environmental and social shareholder proposals at US companies | 7.3% | 110 | 6.8% | 11,096 |
Each ballot item this fund voted is set against the votes of the other Fidelity funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Fidelity funds on 72 items (1.9% of the 3,796 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Fidelity funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Illinois Tool Works Inc. | 2026-05-08 | Shareholder A non-binding stockholder proposal, if properly presented at the meeting, for Directors who fail to obtain a majority vote. | For | AGAINST — 22 of 26 Fidelity funds | Against | Not approved, 11.5% support |
| Inspire Medical Systems, Inc. | 2026-04-30 | Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. | Against | FOR — 14 of 16 Fidelity funds | Against | Approved, 94.4% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To elect eight directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected or appointed: Deneen Howell | Against | FOR — 14 of 16 Fidelity funds | Against | Elected, 98.4% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To elect eight directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected or appointed: Marc Montagner | Against | FOR — 14 of 16 Fidelity funds | Against | Elected, 97.4% support |
| Cogent Communications Holdings, Inc. | 2026-05-01 | To elect eight directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected or appointed: Paul de Sa | Against | FOR — 14 of 16 Fidelity funds | Against | Elected, 97.6% support |
| Inspire Medical Systems, Inc. | 2026-04-30 | Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. | Against | FOR — 13 of 15 Fidelity funds | Against | Approved, 62.0% support |
| Nektar Therapeutics | 2026-06-04 | Election of Directors: Howard W. Robin | Against | FOR — 11 of 13 Fidelity funds | Against | Passed (calculated), 72.6% support |
| Nektar Therapeutics | 2026-06-04 | To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. | Against | FOR — 11 of 13 Fidelity funds | Against | Approved, 72.9% support |
| Hyatt Hotels Corporation | 2026-05-20 | Election of Directors: Class II (to hold office until the 2029 annual meeting of stockholders): Richard C. Tuttle | For | WITHHOLD — 15 of 19 Fidelity funds | For | Elected, 97.0% support |
| Ionis Pharmaceuticals, Inc. | 2026-06-04 | To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. | Against | FOR — 25 of 34 Fidelity funds | Against | Approved, 77.0% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Deirdre A. Mahlan | For | AGAINST — 20 of 27 Fidelity funds | For | Passed (calculated), 95.3% support |
| Prothena Corporation plc | 2026-05-14 | To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. Selkoe | Against | FOR — 12 of 15 Fidelity funds | Against | Elected, 72.8% support |
| Prothena Corporation plc | 2026-05-14 | To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke | Against | FOR — 12 of 15 Fidelity funds | Against | Elected, 65.6% support |
| Block, Inc. | 2026-06-16 | TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: AMY BROOKS | For | WITHHOLD — 17 of 23 Fidelity funds | For | Elected, 82.9% support |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop | Withhold | FOR — 13 of 17 Fidelity funds | Against | — |
| Paylocity Holding Corporation | 2025-12-04 | Approval of the Amended and Restated 2023 Equity Incentive Plan. | Against | FOR — 24 of 35 Fidelity funds | Against | Approved, 96.1% support |
| CCC SA | 2026-01-15 | Shareholder Amend Statute Re: Company Name | Against | FOR — 9 of 11 Fidelity funds | — | — |
| CCC SA | 2026-01-15 | Shareholder Amend Statute Re: Management Board | Against | FOR — 9 of 11 Fidelity funds | — | — |
| CCC SA | 2026-01-15 | Shareholder Authorize Share Repurchase Program; Approve Creation of Reserve Capital for Purposes of Share Repurchase Program | For | AGAINST — 9 of 11 Fidelity funds | — | — |
| Akamai Technologies, Inc. | 2026-05-13 | Shareholder To vote upon a shareholder proposal requiring the Company to provide a report on political spending. | For | AGAINST — 20 of 29 Fidelity funds | Against | Not approved, 45.7% support |
| Akamai Technologies, Inc. | 2026-05-13 | To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies to establish a quorum or if there are insufficient votes to adopt any proposal (other than Proposal 8). | Against | FOR — 20 of 29 Fidelity funds | Against | Approved, 56.7% support |
| Akamai Technologies, Inc. | 2026-05-13 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. | Against | FOR — 20 of 29 Fidelity funds | Against | — |
| Tectonic Therapeutic, Inc. | 2026-06-08 | Election of Directors: Timothy A. Springer, Ph.D. | Withhold | FOR — 12 of 16 Fidelity funds | Against | Passed (calculated), 79.5% support |
| Nutanix, Inc. | 2025-12-12 | Approval of the amendment and restatement of our 2016 Equity Incentive Plan. | Against | FOR — 23 of 35 Fidelity funds | Against | Approved, 76.5% support |
| Revolve Group, Inc. | 2026-06-05 | The election of directors: Michael Mente | Withhold | FOR — 13 of 18 Fidelity funds | Against | Elected, 93.3% support |
| Company | Meeting | Item | This fund | Most Fidelity funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| ODDITY Tech Ltd. | 2025-11-13 | Reelect Shiran Holtzman-Erel as Director | Against | FOR — 8 of 10 Fidelity funds | Against | — |
| Albemarle Corporation | 2026-05-05 | Shareholder Shareholder Proposal regarding shareholders ability to call for a special shareholder meeting. | Against | FOR — 18 of 27 Fidelity funds | For | Approved, 57.5% support |
| Workday, Inc. | 2026-06-16 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. | For | AGAINST — 20 of 31 Fidelity funds | For | Approved, 87.6% support |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Keith Manchester | Withhold | FOR — 16 of 24 Fidelity funds | Against | Elected, 70.6% support |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew Gline | Withhold | FOR — 16 of 24 Fidelity funds | Against | Elected, 73.6% support |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Melissa Epperly | Withhold | FOR — 16 of 24 Fidelity funds | Against | Elected, 73.5% support |
| Nuvation Bio Inc. | 2026-05-21 | Election of Directors: Robert Bazemore | For | WITHHOLD — 12 of 17 Fidelity funds | For | Elected, 84.0% support |
| Circle Internet Group, Inc. | 2026-05-14 | Election of Three Class I Directors: P. Sean Neville | Against | FOR — 17 of 26 Fidelity funds | Against | Elected, 89.6% support |
| Globus Medical, Inc. | 2026-06-03 | Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil | Withhold | FOR — 18 of 28 Fidelity funds | Against | Elected, 91.3% support |
| The Trade Desk, Inc. | 2026-05-04 | The election of two Class I directors to hold office until our 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified: Jeff T. Green | Withhold | FOR — 19 of 30 Fidelity funds | Against | Passed (calculated), 92.5% support |
| Summit Therapeutics Inc. | 2026-06-10 | ELECTION OF DIRECTORS: Kenneth A. Clark | Withhold | FOR — 15 of 23 Fidelity funds | Against | Passed (calculated), 96.1% support |
| Summit Therapeutics Inc. | 2026-06-10 | ELECTION OF DIRECTORS: Mahkam Zanganeh | Withhold | FOR — 15 of 23 Fidelity funds | Against | Passed (calculated), 98.5% support |
| Summit Therapeutics Inc. | 2026-06-10 | ELECTION OF DIRECTORS: Manmeet S. Soni | Withhold | FOR — 15 of 23 Fidelity funds | Against | Passed (calculated), 98.4% support |
| Summit Therapeutics Inc. | 2026-06-10 | ELECTION OF DIRECTORS: Robert W. Duggan | Withhold | FOR — 15 of 23 Fidelity funds | Against | Passed (calculated), 98.3% support |
| Summit Therapeutics Inc. | 2026-06-10 | ELECTION OF DIRECTORS: Yu (Michelle) Xia | Withhold | FOR — 15 of 23 Fidelity funds | Against | Passed (calculated), 98.3% support |
| SkinHealth Systems Inc. | 2026-06-10 | Election of Directors: Brian Miller | Withhold | FOR — 7 of 9 Fidelity funds | Against | Elected, 78.6% support |
| SkinHealth Systems Inc. | 2026-06-10 | Election of Directors: Doug Schillinger | Withhold | FOR — 7 of 9 Fidelity funds | Against | Elected, 84.9% support |
| SkinHealth Systems Inc. | 2026-06-10 | Election of Directors: E. Scott Beattie | Withhold | FOR — 7 of 9 Fidelity funds | Against | Elected, 84.8% support |
| Rivian Automotive, Inc. | 2026-06-22 | Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders: Aidan Gomez | Withhold | FOR — 19 of 31 Fidelity funds | Against | Passed (calculated), 92.4% support |
| Summit Therapeutics Inc. | 2026-06-10 | Approval, by a non-binding advisory vote, of the compensation of our named executive officers. | For | AGAINST — 17 of 27 Fidelity funds | For | Passed (calculated), 96.2% support |
| Atea Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: Jerome Adams, MD, MPH | Withhold | FOR — 12 of 18 Fidelity funds | Against | Passed (calculated), 56.4% support |
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Election of Directors: Hongbo Lu | Against | FOR — 14 of 22 Fidelity funds | Against | — |
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Election of Directors: William Waddill | Against | FOR — 14 of 22 Fidelity funds | Against | Passed (calculated), 90.3% support |
| Southwest Airlines Co. | 2026-05-07 | Election of Directors: Sarah E. Feinberg | Against | FOR — 19 of 33 Fidelity funds | Against | Passed (calculated), 94.8% support |
| Duolingo, Inc. | 2026-06-03 | Election of Class II Directors: Amy Bohutinsky | For | WITHHOLD — 17 of 29 Fidelity funds | For | Passed (calculated), 92.6% support |
| Foghorn Therapeutics Inc. | 2026-06-24 | Elect Class III directors each for a three-year term: Douglas Cole, M.D. | Against | FOR — 7 of 10 Fidelity funds | Against | Elected, 76.2% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Fred Wilson | Withhold | FOR — 22 of 41 Fidelity funds | Against | Elected, 99.3% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Kelly A. Kramer | Withhold | FOR — 22 of 41 Fidelity funds | Against | Elected, 99.4% support |
| Wayfair Inc. | 2026-05-21 | Election of Nine Directors: Andrea Jung | Abstain | FOR — 19 of 34 Fidelity funds | Against | — |
| Wayfair Inc. | 2026-05-21 | Election of Nine Directors: Michael E. Sneed | Abstain | FOR — 19 of 34 Fidelity funds | Against | — |
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Election of Directors: Michael S. Perry | Against | FOR — 13 of 22 Fidelity funds | Against | — |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | For | WITHHOLD — 16 of 28 Fidelity funds | For | Elected, 77.8% support |
| Rivian Automotive, Inc. | 2026-06-22 | Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders: Karen Boone | Withhold | FOR — 17 of 31 Fidelity funds | Against | Passed (calculated), 81.4% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Frederick Ernest Ehrsam III | Withhold | FOR — 21 of 41 Fidelity funds | Against | Elected, 97.0% support |
| Coinbase Global, Inc. | 2026-06-16 | Election of Directors: Marc L. Andreessen | Withhold | FOR — 21 of 41 Fidelity funds | Against | Elected, 97.1% support |
| EquipmentShare.com Inc | 2026-06-04 | To elect to the Board of Directors seven nominees for one-year terms: Jennifer Giacomazza | Withhold | FOR — 5 of 7 Fidelity funds | Against | Elected, 98.6% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Richard P. Wong | For | AGAINST — 16 of 31 Fidelity funds | For | Passed (calculated), 94.8% support |
| Southwest Airlines Co. | 2026-05-07 | Election of Directors: Lisa M. Atherton | Against | FOR — 17 of 33 Fidelity funds | Against | Passed (calculated), 91.0% support |
| Southwest Airlines Co. | 2026-05-07 | Election of Directors: Patricia A. Watson | Against | FOR — 17 of 33 Fidelity funds | Against | Passed (calculated), 92.3% support |
| Southwest Airlines Co. | 2026-05-07 | Election of Directors: Rakesh Gangwal | Against | FOR — 17 of 33 Fidelity funds | Against | Passed (calculated), 90.9% support |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Arthur T. Sands, M.D., Ph.D. | Withhold | FOR — 13 of 24 Fidelity funds | Against | Elected, 79.6% support |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Paul M. Silva | Withhold | FOR — 13 of 24 Fidelity funds | Against | Elected, 74.2% support |
| SkinHealth Systems Inc. | 2026-06-10 | Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. | Against | FOR — 7 of 11 Fidelity funds | Against | Approved, 82.6% support |
| Biomea Fusion, Inc. | 2026-06-10 | The election of Rainer (Ramses) Erdtmann and Eric Aguiar, M.D., as Class II Directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2029: Rainer (Ramses) Erdtmann | Withhold | FOR — 4 of 7 Fidelity funds | Against | — |
| CAMP4 Therapeutics Corporation | 2026-06-10 | Election of the following nominees as our Class II Directors, each to serve for a three-year term until the 2029 annual meeting of our stockholders, and until his successor shall have been duly elected and qualified: Murray Stewart, DM FRCP | Against | FOR — 4 of 7 Fidelity funds | Against | — |
| CAMP4 Therapeutics Corporation | 2026-06-10 | Election of the following nominees as our Class II Directors, each to serve for a three-year term until the 2029 annual meeting of our stockholders, and until his successor shall have been duly elected and qualified: Richard Young, PhD | Against | FOR — 4 of 7 Fidelity funds | Against | — |
| CAMP4 Therapeutics Corporation | 2026-06-10 | Election of the following nominees as our Class II Directors, each to serve for a three-year term until the 2029 annual meeting of our stockholders, and until his successor shall have been duly elected and qualified: Steven Holtzman | Against | FOR — 4 of 7 Fidelity funds | Against | — |
Download all 72 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 83.8% of this fund’s 3,856 such votes could be given a sector; the other 624 (16.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 794 | 65 | 8.2% |
| Technology | 787 | 71 | 9.0% |
| Health Care | 683 | 11 | 1.6% |
| Industrials | 329 | 23 | 7.0% |
| Consumer Staples | 228 | 16 | 7.0% |
| Finance | 180 | 18 | 10.0% |
| Telecommunications | 81 | 5 | 6.2% |
| Energy | 79 | 1 | 1.3% |
| Real Estate | 38 | 1 | 2.6% |
| Basic Materials | 28 | 0 | 0.0% |
| Utilities | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,522 | 0 |
| Audit-related | 364 | 0 |
| Say-on-Pay | 320 | 0 |
| Corporate Governance | 247 | 80 |
| Compensation | 187 | 5 |
| Capital Structure | 114 | 0 |
| Other Social Issues | 48 | 45 |
| Environment or Climate | 47 | 47 |
| Shareholder Rights and Defenses | 24 | 15 |
| Human Rights or Human Capital/workforce | 16 | 16 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| NVIDIA Corporation | June 24, 2026 | $3.0B | 16 | 4 |
| Apple Inc. | February 24, 2026 | $2.1B | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $1.6B | 21 | 6 |
| Meta Platforms, Inc. | May 27, 2026 | $1.5B | 22 | 9 |
| Amazon.com, Inc. | May 20, 2026 | $1.3B | 17 | 4 |
| Sandisk Corporation | November 18, 2025 | $1.2B | 10 | 0 |
| Alphabet Inc. | June 5, 2026 | $853M | 23 | 10 |
| Eli Lilly and Company | May 4, 2026 | $704M | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | For | Against |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | For | Against |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
3,902 ballot items at 377 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Fidelity Series Growth Company Fund (FCGSX) voted at 377 shareholder meetings of 359 companies, on 3,902 ballot items in all. Where management made a recommendation, the fund followed it on 94.3% of the items and voted against it 211 times. Its most frequent area of disagreement was corporate governance (80 of its votes against management). It voted FOR 16.7% of the 221 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Fidelity's funds as a whole (92.9% against 94.1%). It voted differently from most Fidelity funds on 72 items. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Fidelity’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.